Playback speed
10 seconds
This video is featured in the 2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Avelumab in Early TNBC With Residual Disease After Neoadjuvant Chemo or at High Risk After Primary Surgery and Adjuvant Chemo"
By
ecancer
FEATURING
Pierfranco Conte
By
ecancer
FEATURING
Pierfranco Conte
34 views
July 2, 2024
Login to view comments.
Click here to Login